Crossref

1. Efficacy of Anti-Interleukin-2 Receptor Antibody in Reducing the Incidence of Acute Rejection After Renal Transplantation

- Alexandre Braga Liborio

- Tacyano Tavares Leite

2. Clinical management of multiple sclerosis and neuromyelitis optica with therapeutic monoclonal antibodies: approved therapies and emerging candidates

- Divyanshu Dubey

- Bernd C Kieseier

- Hans Peter Hartung

- Bernhard Hemmer

- William A Miller-Little

- Olaf Stuve

3. VLA-4 blockade promotes differential routes into human CNS involving PSGL-1 rolling of T cells and MCAM-adhesion of TH17 cells

- Tilman Schneider-Hohendorf

- Jan Rossaint

- Hema Mohan

- Daniel Böning

- Johanna Breuer

- Tanja Kuhlmann

- Catharina C. Gross

- Ken Flanagan

- Lydia Sorokin

- Dietmar Vestweber

- Alexander Zarbock

- Nicholas Schwab

- Heinz Wiendl

4. Induction of PD-L1 on monocytes: A new mechanism by which IVIg inhibits mixed lymphocyte reactions

- Lauriane Padet

- Lionel Loubaki

- Renée Bazin

5. Peptides, Antibodies, Peptide Antibodies and More

- Nicole Trier

- Paul Hansen

- Gunnar Houen

6. Therapeutic uses of anti-α4-integrin (anti-VLA-4) antibodies in multiple sclerosis

- Nicholas Schwab

- Tilman Schneider-Hohendorf

- Heinz Wiendl

7. Efficacy of plasmapheresis on donor‐specific antibody reduction by HLA specificity in post–kidney transplant recipients

- Chisa Yamada

- Daniel S. Ramon

- Marilia Cascalho

- Randall S. Sung

- Alan B. Leichtman

- Milagros Samaniego

- Robertson D. Davenport